201 related articles for article (PubMed ID: 34297529)
1. Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation.
Singh AK; Singh SS; Rathore AS; Singh SP; Mishra G; Awasthi R; Mishra SK; Gautam V; Singh SK
ACS Biomater Sci Eng; 2021 Aug; 7(8):3737-3753. PubMed ID: 34297529
[TBL] [Abstract][Full Text] [Related]
2. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin Loaded Amino-Functionalized MCM-48 Mesoporous Silica Nanoparticles as a Promising Drug Carrier in Bone Substitutes for Bacterial Infection Management.
Rahaman SN; Pathmanapan S; Sidharthan A; Anandasadagopan SK
Appl Biochem Biotechnol; 2023 Nov; 195(11):6607-6632. PubMed ID: 36892681
[TBL] [Abstract][Full Text] [Related]
4. Intranasally Co-administered Berberine and Curcumin Loaded in Transfersomal Vesicles Improved Inhibition of Amyloid Formation and BACE-1.
Mishra G; Awasthi R; Singh AK; Singh S; Mishra SK; Singh SK; Nandi MK
ACS Omega; 2022 Nov; 7(47):43290-43305. PubMed ID: 36467923
[TBL] [Abstract][Full Text] [Related]
5. MCM-41 Nanoparticles for Brain Delivery: Better Choline-Esterase and Amyloid Formation Inhibition with Improved Kinetics.
Pandey PK; Sharma AK; Rani S; Mishra G; Kandasamy G; Patra AK; Rana M; Sharma AK; Yadav AK; Gupta U
ACS Biomater Sci Eng; 2018 Aug; 4(8):2860-2869. PubMed ID: 33435009
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System.
Ghahfarokhi MR; Dini G; Movahedi B
Curr Drug Deliv; 2022; 19(1):64-73. PubMed ID: 34151762
[TBL] [Abstract][Full Text] [Related]
7.
Singh AK; Singh S; Minocha T; Yadav SK; Narayan R; Nayak UY; Singh SK; Awasthi R
Nanoscale Adv; 2024 Apr; 6(9):2469-2486. PubMed ID: 38694466
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Oral Administration of Mesoporous Silica Nanoparticles Potentially Induced Colon Inflammation in Rats Through Alteration of Gut Microbiota.
Yu Y; Wang Z; Wang R; Jin J; Zhu YZ
Int J Nanomedicine; 2021; 16():881-893. PubMed ID: 33574668
[TBL] [Abstract][Full Text] [Related]
9. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
10. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats.
Fahmy HM; Ahmed MM; Mohamed AS; Shams-Eldin E; Abd El-Daim TM; El-Feky AS; Mustafa AB; Abd Alrahman MW; Mohammed FF; Fathy MM
BMC Pharmacol Toxicol; 2022 Sep; 23(1):71. PubMed ID: 36163187
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a temperature-responsive nanocarrier for imidacloprid based on mesoporous silica nanoparticles.
Yao P; Zou A; Tian Z; Meng W; Fang X; Wu T; Cheng J
Colloids Surf B Biointerfaces; 2021 Feb; 198():111464. PubMed ID: 33296822
[TBL] [Abstract][Full Text] [Related]
12. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy.
Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L
Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825
[TBL] [Abstract][Full Text] [Related]
13. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
14. Combined Therapy of Experimental Autoimmune Uveitis by a Dual-Drug Nanocomposite Formulation with Berberine and Dexamethasone.
Huang C; Zhang Z; Gu J; Li D; Gao S; Zhang R; Shi R; Sun J
Int J Nanomedicine; 2023; 18():4347-4363. PubMed ID: 37545873
[TBL] [Abstract][Full Text] [Related]
15. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
16. Imidacloprid-loaded mesoporous silica nanoparticles simultaneously coated with myristyl alcohol and polydopamine for NIR-triggered delivery on Aphis craccivora Koch.
Yu S; Xu W; Xiao W; Li S; Zou A
Colloids Surf B Biointerfaces; 2022 Dec; 220():112882. PubMed ID: 36240575
[TBL] [Abstract][Full Text] [Related]
17. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
18. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
[TBL] [Abstract][Full Text] [Related]
19. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
20. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
Feng Y; Li NX; Yin HL; Chen TY; Yang Q; Wu M
Mol Pharm; 2019 Jan; 16(1):422-436. PubMed ID: 30525641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
